Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology

被引:32
|
作者
Huang, YB [1 ]
Tsai, YH [1 ]
Yang, WC [1 ]
Chang, JS [1 ]
Wu, PC [1 ]
机构
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung 80708, Taiwan
关键词
propranolol; hydroxypropylmethyleellulose (HPMC); dissolution test; response surface methodology;
D O I
10.1248/bpb.27.1626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to develop propranolol extended release formulations containing hydroxypropylmethylcellulose (HPMC). The results indicate that the drug release from the tablet form containing a high amount of HPMC was incomplete, and avicel addition could increase the release percent at a later stage. In order to readily obtain an optimal formulation, response surface methodology and multiple response optimization utilizing a quadratic polynomial equation was used. The model formulations were prepared according to a factorial design. The effects of causal factors including the HPMC/drug ratio (X-1) and avicel level (X-2), on drug release were also measured. The drug release percentage at 1.5, 4, 8, 14 and 24 It were the target response and were restricted to not more than 25%, 35-50%, 55-70%, 75-90%, and 95-110%, respectively. The results showed that the optimized formulation provided a dissolution pattern equivalent to the predicted curve, which indicated that the optimal formulation could be obtained using response surface methodology. The mechanism of drug release from HMPC matrices tablets followed quasi-Fickian diffusion.
引用
收藏
页码:1626 / 1629
页数:4
相关论文
共 50 条
  • [1] Design and Optimization of Sustained-Release Divalproex Sodium Tablets with Response Surface Methodology
    Farnaz Monajjemzadeh
    Hamed Hamishehkar
    Parvin Zakeri-Milani
    Afsaneh Farjami
    Hadi Valizadeh
    [J]. AAPS PharmSciTech, 2013, 14 : 245 - 253
  • [2] Design and Optimization of Sustained-Release Divalproex Sodium Tablets with Response Surface Methodology
    Monajjemzadeh, Farnaz
    Hamishehkar, Hamed
    Zakeri-Milani, Parvin
    Farjami, Afsaneh
    Valizadeh, Hadi
    [J]. AAPS PHARMSCITECH, 2013, 14 (01): : 245 - 253
  • [3] SUSTAINED-RELEASE DOSAGE FORM OF PHENYLPROPANOLAMINE HYDROCHLORIDE .3. APPLICATION OF FACTORIAL DESIGN
    SEVGI, F
    OZYAZICI, M
    GUNERI, T
    [J]. JOURNAL OF MICROENCAPSULATION, 1994, 11 (04) : 439 - 444
  • [4] Sustained-release dosage form of nicardipine hydrochloride: Application of factorial design and effect of surfactant on release kinetics
    Ozyazici, M
    Sevgi, F
    Ertan, G
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) : 761 - 770
  • [5] Optimization of propranolol hydrochloride sustained release pellets using a factorial design
    Bodea, A
    Leucuta, SE
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) : 49 - 57
  • [6] Optimization of calcium pectinate gel beads for sustained-release of catechin using response surface methodology
    Lee, Ji-Soo
    Chung, Donghwa
    Lee, Hyeon Gyu
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2008, 42 (04) : 340 - 347
  • [7] Pharmacokinetics of a sustained-release dosage form of clomipramine
    Herrera, D
    Mayet, L
    Galindo, MD
    Jung, H
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1488 - 1493
  • [8] DEVELOPMENT OF A SUSTAINED-RELEASE DOSAGE FORM FOR GLYBURIDE
    KITTAYANOND, D
    ZUCK, DA
    WALLACE, SM
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (04): : C8 - C8
  • [9] Tablet Compression Optimization of Ivabradine Sustained-Release Tablet Using Full Factorial Design
    Kim, Kang Min
    Cao, Shugeng
    Pyo, Jae Sung
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (03) : 730 - 735
  • [10] A NEW ORAL GELATINIZED SUSTAINED-RELEASE DOSAGE FORM
    TANAKA, N
    UTSUMI, I
    TAKINO, S
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (07) : 664 - &